Evidence map›Paper›PMID 37534444›Full record

Observational studyInternational journal of immunopathology and pharmacology

Use of canakinumab and remdesivir in moderate-severe COVID-19 patients: A retrospective analysis.

Antonio Mastroianni, Valeria Vangeli, Luciana Chidichimo, Filippo Urso, Giuseppe De Marco, Alfredo Zanolini, Francesca Greco, Maria V Mauro, Sonia Greco

Open access · goldAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in International journal of immunopathology and pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. NLRP3 Inflammasomes: Dual Function in Infectious Diseases.Journal of immunology (Baltimore, Md. : 1950) · 2024
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Antonio MastroianniInfectious & Tropical Diseases Unit, "Annunziata" Hospital, Azienda Ospedaliera di Cosenza, Cosenza, Italy.ORCID 0000-0002-1641-1491
Valeria VangeliInfectious & Tropical Diseases Unit, "Annunziata" Hospital, Azienda Ospedaliera di Cosenza, Cosenza, Italy.
Luciana ChidichimoInfectious & Tropical Diseases Unit, "Annunziata" Hospital, Azienda Ospedaliera di Cosenza, Cosenza, Italy.
Filippo UrsoHospital Pharmacy, "Annunziata" Hospital, Azienda Ospedaliera di Cosenza, Cosenza, Italy.
Giuseppe De MarcoHospital Pharmacy, "Annunziata" Hospital, Azienda Ospedaliera di Cosenza, Cosenza, Italy.
Alfredo ZanoliniRadiology Unit, "Annunziata" Hospital, Azienda Ospedaliera di Cosenza, Cosenza, Italy.
Francesca GrecoMicrobiology & Virology Unit, "Annunziata" Hospital, Azienda Ospedaliera di Cosenza, Cosenza, Italy.
Maria V MauroMicrobiology & Virology Unit, "Annunziata" Hospital, Azienda Ospedaliera di Cosenza, Cosenza, Italy.
Sonia GrecoInfectious & Tropical Diseases Unit, "Annunziata" Hospital, Azienda Ospedaliera di Cosenza, Cosenza, Italy.
Azienda Ospedaliera di Cosenza · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Adenosine MonophosphateAdultAgedAged, 80 and overAlanineAntibodies, Monoclonal, HumanizedAntiviral AgentsCOVID-19 Drug TreatmentHumansMiddle AgedRetrospective StudiesSARS-CoV-2Treatment OutcomeAdenosine MonophosphateAlanineAntibodies, Monoclonal, HumanizedAntiviral AgentscanakinumabremdesivircanakinumabCOVID-19hematological markersinflammatory markersremdesivir

Identifiers

PMID37534444
PMCPMC10402280
OpenAlexW4385514099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.